Therapeutic Interchange of Parenteral Anticoagulants: Challenges for Pharmacy and Therapeutics Committees
This is a review of key factors for pharmacy and therapeutics committees to consider when developing a therapeutic interchange (TI) program for venous thromboembolism (VTE) prophylaxis. Recent patient safety initiatives aimed at reducing the incidence of hospital-acquired VTE may increase the prescr...
Saved in:
Main Author: | Alpesh Amin (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2011-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Generic antihypertensive medications with therapeutic interchangeability requirements
by: Giulianna Gamero-Vega, et al.
Published: (2019) -
Interchangeability among therapeutic equivalents of lamotrigine: evaluation of quality of life
by: Beatriz Maria Pereira Girolineto, et al.
Published: (2012) -
Medicines and hospitals brazilian health system: the impact of pharmacy and therapeutics committees
by: Rafael Santos Santana, et al.
Published: (2018) -
Assessment of the structure and activities of pharmacy and therapeutics committees of public sector hospitals, Gauteng Province, South Africa
by: M. Matlala, et al.
Published: (2015) -
Drug assessment by a Pharmacy and Therapeutics committee: from drug selection criteria to use in clinical practice
by: Lozano-Blázquez A, et al.
Published: (2014)